The Department of Urology has a longstanding tradition of education and care related to urologic cancers of the bladder, kidney, testis, and related organs.
Faculty members care for patients through Feinberg-affiliated hospitals and care sites. For Urologic oncology patients, we pursue a multidisciplinary approach to the evaluation and management with recognized experts specializing in each branch of cancer care. The integrated approach with input from all related services allows for the formulation of an appropriate treatment plan individualized for each patient based upon tumor stage, medical condition, and patient preferences.
Selected Research Publications
Tosoian JJ, Sundi D, Trock BJ, Landis P, Epstein JI, Schaeffer EM, Carter HB, Mamawala M. Pathologic Outcomes in Favorable-Risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. This report compares men with favorable-risk prostate cancer who elected active surveillance with those who underwent immediate surgery.
Carneiro BA, Meeks JJ, Kuzel TM, Scaranti M, Abdulkadir SA, Giles FJ. Emerging Therapeutic Targets in Bladder Cancer. An examination of a new therapeutic targets and treatment strategies to improve the outcome of patients affected by bladder cancer.
Meeks JJ, Gonzalez CM. Standard of Care for Small Renal Masses in the 21st Century. A review of treatment guidelines for renal cancers less than 4 cm.
Shilajit D. Kundu, MD
Section Director, Urologic Oncology
William J. Catalona, MD
Stephanie J. Kielb, MD
Joshua J. Meeks, MD, PhD
Robert B. Nadler, MD
Kent T. Perry, MD
Edward M. Schaeffer, MD, PhD